
Reset all filters
01 14Merck Canada Inc.
Reset all filters
01 22450740
02 22529400
03 22536251
04 82733795
Reset all filters
01 2ERTUGLIFLOZIN
02 4ERTUGLIFLOZIN | METFORMIN HYDROCHLORIDE
03 8ERTUGLIFLOZIN | SITAGLIPTIN PHOSPHATE
Reset all filters
01 14TABLET
Reset all filters
01 22022-07-05
02 22024-06-18
03 22024-08-27
04 82029-08-17
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
Brand Name : STEGLATRO
Patent Number : 2733795
Filing Date : 2009-08-17
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
Brand Name : STEGLATRO
Patent Number : 2733795
Filing Date : 2009-08-17
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2733795
Filing Date : 2009-08-17
Strength per Unit : 15 mg / 100mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-08-27
Date Granted : 2009-08-04
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2536251
Filing Date : 2004-08-27
Strength per Unit : 15 mg / 100mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-08-27
Date Granted : 2009-08-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-06-18
Date Granted : 2007-10-09
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2529400
Filing Date : 2004-06-18
Strength per Unit : 15 mg / 100mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-06-18
Date Granted : 2007-10-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 15 mg / 100mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-08-27
Date Granted : 2009-08-04
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2536251
Filing Date : 2004-08-27
Strength per Unit : 5 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-08-27
Date Granted : 2009-08-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2450740
Filing Date : 2002-07-05
Strength per Unit : 5 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-07-05
Date Granted : 2006-02-14
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-06-18
Date Granted : 2007-10-09
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2529400
Filing Date : 2004-06-18
Strength per Unit : 5 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-06-18
Date Granted : 2007-10-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE
Brand Name : STEGLUJAN
Patent Number : 2733795
Filing Date : 2009-08-17
Strength per Unit : 5 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-08-17
Date Granted : 2013-12-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF